Quick Answer
Alaunos Therapeutics, Inc. reported Total Assets of $2.97 million for fiscal year 2025.
Alaunos Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $2.97M | +7.7% |
| 2024 | $2.75M | -66.7% |
| 2023 | $8.26M | -87.3% |
| 2022 | $64.94M | -31.5% |
| 2021 | $94.86M | -35.2% |
| 2020 | $146.34M | +34.1% |
| 2019 | $109.11M | +14.8% |
| 2018 | $95.05M | -10.0% |
| 2017 | $105.61M | -0.7% |
| 2016 | $106.35M | -30.8% |
| 2015 | $153.72M | +239.8% |
| 2014 | $45.24M | -37.0% |
| 2013 | $71.75M | -14.0% |
| 2012 | $83.40M | -22.9% |
| 2011 | $108.11M | +75.7% |
| 2010 | $61.52M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.72M | +4.9% | -21.4% |
| June 30, 2025 | $4.74M | +1.2% | +123.3% |
| March 31, 2025 | $2.12M | -64.9% | -23.0% |
| December 31, 2024 | $2.75M | -66.7% | -22.4% |
| September 30, 2024 | $3.55M | -81.7% | -24.1% |
| June 30, 2024 | $4.68M | -83.2% | -22.5% |
| March 31, 2024 | $6.04M | -87.6% | -26.9% |
| December 31, 2023 | $8.26M | -87.3% | -57.5% |
- Alaunos Therapeutics, Inc. showed an increase of +7.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Alaunos Therapeutics, Inc.’s total assets has declined by 95.2% (from $61.52 million to $2.97 million).
- The most recent figure is from Alaunos Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: